Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
From cancer research to diagnostic solutions
The Theme of the event was 'Building One Health Together – Improving Health Equity'
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Affordability is key to providing accessible healthcare for Bharat.
The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Urges everyone to follow COVID Appropriate Behaviour and curb any misinformation
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma
Subscribe To Our Newsletter & Stay Updated